1. Therapeutic Potential of Phosphodiesterase Inhibitors for Endothelial Dysfunction- Related Diseases
   Javier Blanco-Rivero et al, 2020, Current Pharmaceutical Design CrossRef
2. Prospects of clinical application of cilostazol for peripheral artery disease
   E. P. Burleva et al, 2020, Angiology and vascular surgery CrossRef
3. Angiotensin II-induced vascular endothelial cells ferroptosis via P53-ALOX12 signal axis
   Chi Liu et al, 2023, Clinical and Experimental Hypertension CrossRef
4. Mechanisms and Clinical Implications of Endothelial Dysfunction in Arterial Hypertension
   Pasquale Ambrosino et al, 2022, Journal of Cardiovascular Development and Disease CrossRef
5. Dual antiplatelet therapy using cilostazol for secondary prevention in patients with high-risk ischaemic stroke in Japan: a multicentre, open-label, randomised controlled trial
   Kazunori Toyoda et al, 2019, The Lancet Neurology CrossRef
6. Long-term effectiveness and safety of cilostazol versus clopidogrel in secondary prevention of noncardioembolic ischemic stroke
   Yu Jeong Lee et al, 2023, European Journal of Clinical Pharmacology CrossRef
7. Cilostazol protects mice against myocardium ischemic/reperfusion injury by activating a PPARγ/JAK2/STAT3 pathway
   Jiangjin Li et al, 2017, Biomedicine & Pharmacotherapy CrossRef
8. Cilostazol Stimulates Angiogenesis and Accelerates Fracture Healing in Aged Male and Female Mice by Increasing the Expression of PI3K and RUNX2
   Maximilian M. Menger et al, 2024, International Journal of Molecular Sciences CrossRef